[ad_1]
The scientific instrument maker Bruker has acquired two smaller firms to bolster its optic offerings. One is Spectral Instruments Imaging, which makes devices that use bioluminescence, fluorescence, and X-ray illumination for in vivo, preclinical imaging for disease research. Bruker also bought the Raman microscope maker Nanophoton, saying that it will fill a gap in the firm’s molecular microscopy portfolio. The microscopes are used to analyze advanced materials such as semiconductors and to map small-molecule distribution in drug formulations and ex vivo tissue samples. Bruker says Spectral was profitable in 2023 on sales of around $10 million, while Nanophoton was “near break even” and had $5 million in sales.
[ad_2]
Source link
